Ronald Muhlenkamp
Muhlenkamp & Co
Ronald Muhlenkamp Alerian MLP ETF stake
total: 197
Muhlenkamp & Co AMLP trades
- Total transactions:
- 27
- New positions:
- 2
- Sold out:
- 1
- Added:
- 15
- Reduced:
- 9
- Held since:
- 2018 Q1
- Held for:
- 31 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q2 report, Ronald Muhlenkamp holds 150,615 Alerian MLP ETF (AMLP) shares with a market value of roughly $7.81M accounting for 2.26% of the overall portfolio. To date, the estimated cost basis is nearly $10.47 for "buy" trades and estimated average "sell" price is $27.31. Muhlenkamp & Co first purchased AMLP in 2015 Q4, initially acquiring 831,070 shares. Ronald Muhlenkamp later completely sold out the position and invested in Alerian MLP ETF again in 2018 Q1. Since the initial investment in Alerian MLP ETF (AMLP), Muhlenkamp & Co has made 26 more transactions.
When did Ronald Muhlenkamp buy Alerian MLP ETF (AMLP)?
Ronald Muhlenkamp first invested in Alerian MLP ETF (AMLP) in 2015 Q4 at the reported quarter-end price of $12.05 per share.
What's the cost basis of Muhlenkamp & Co's AMLP stake?
The estimated cost basis for Alerian MLP ETF (AMLP) stake is around $10.47 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $10.47
- Weighted AVG sell price:
- $27.31
Ronald Muhlenkamp's historical trades in Alerian MLP ETF
27 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
2.09%
|
150,615
|
$52.64
|
$7,928,374
|
-14.57% (-25,686)
|
-0.36%
|
|
2025 Q4
|
2.23%
|
176,301
|
$47.02
|
$8,289,673
|
-0.24% (-420)
|
-0.01%
|
|
2025 Q3
|
2.25%
|
176,721
|
$46.93
|
$8,293,497
|
+0.01% (+9)
|
+0%
|
|
2025 Q2
|
2.69%
|
176,712
|
$48.86
|
$8,634,160
|
+0.00% (+8)
|
+0%
|
|
2025 Q1
|
3.00%
|
176,704
|
$51.94
|
$9,178,015
|
+0.91% (+1,595)
|
+0.03%
|
|
2024 Q4
|
2.56%
|
175,109
|
$48.16
|
$8,433,238
|
+0.00% (+8)
|
+0%
|
|
2024 Q3
|
2.53%
|
175,101
|
$47.13
|
$8,252,512
|
+0.31% (+546)
|
+0.01%
|
|
2023 Q2
|
2.43%
|
174,555
|
$39.21
|
$6,844,302
|
-38.61% (-109,762)
|
-1.82%
|
|
2022 Q4
|
4.59%
|
284,317
|
$38.07
|
$10,823,948
|
+0.09% (+260)
|
+0%
|
|
2022 Q3
|
4.64%
|
284,057
|
$36.56
|
$10,385,000
|
+1.05% (+2,957)
|
+0.05%
|
|
2022 Q2
|
4.53%
|
$34.45
|
-0.21% (-593)
|
|||
|
2022 Q1
|
3.76%
|
$38.30
|
+0.53% (+1,493)
|
|||
|
2021 Q4
|
3.20%
|
$32.74
|
-0.08% (-236)
|
|||
|
2021 Q3
|
3.59%
|
$33.33
|
-0.16% (-451)
|
|||
|
2021 Q2
|
3.75%
|
$36.41
|
+0.16% (+451)
|
|||
|
2021 Q1
|
3.36%
|
$32.43
|
+8.83% (+22,744)
|
|||
|
2020 Q4
|
2.66%
|
$25.66
|
+1.15% (+2,936)
|
|||
|
2020 Q3
|
2.64%
|
$19.98
|
+0.90% (+2,269)
|
|||
|
2020 Q2
|
3.33%
|
$24.68
|
-73.18% (-688,942)
|
|||
|
2019 Q4
|
3.50%
|
$8.50
|
+20.45% (+159,828)
|
|||
|
2019 Q3
|
3.48%
|
$9.14
|
+0.06% (+438)
|
|||
|
2019 Q2
|
3.74%
|
$9.85
|
-0.33% (-2,590)
|
|||
|
2019 Q1
|
3.72%
|
$10.03
|
+333.09% (+602,784)
|
|||
|
2018 Q3
|
0.83%
|
$10.68
|
-3.61% (-6,773)
|
|||
|
2018 Q1
|
0.64%
|
$9.37
|
new
|
|||
|
2016 Q1
|
0.00%
|
$12.05
|
-100% (-831,070)
|
|||
|
2015 Q4
|
3.16%
|
$12.05
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.